, Update on overall prevalence of major birth defects, 1978.

, MMWR Morb Mortal Wkly Rep, vol.57, pp.1-5, 2008.

K. Lee, B. Khoshnood, and L. Chen, Infant mortality from congenital malformations in the United States, Obstet Gynecol, vol.98, pp.620-627, 1970.

F. Hatton, M. H. Bouvier-colle, and B. Blondel, Trends in infant mortality in France: frequency and causes from 1950 to, Arch Pediatr, vol.7, pp.489-500, 1997.

T. J. Matthews, M. F. Macdorman, and M. E. Thoma, Infant mortality statistics from the 2013 period linked birth/infant death data set, Natl Vital Stat Rep, vol.64, pp.1-30, 2015.

C. Sureau and R. Henrion, Assessment by the national committee for ulstrasound prenatal screening CNTE (Comité National Technique de l'Echographie de dépistage prénatal) report, 2005.

F. Law, Legislation: Arrêté du 23 juin 2009 fixant les règles de bonnes pratiques en matière de dépistage et de diagnostic prénatals avec utilisation des marqueurs sériques maternels de la trisomie 21, bylaw establishing guidelines for prenatal screening and diagnosis

, LOI no 94-654 du 29 juillet 1994 relative au don et à l'utilisation des éléments et produits du corps humain, à l'assistance médicale à la procréation et au diagnostic prénatal, French Law: law on organ donation, medically assisted procreation and prenatal diagnosisi Legislation

F. Law, law on terminataion of pregnancy for medical reasons Legislation. LOI no 2001-588 du 4 juillet 2001 relative à l'interruption volontaire de grossesse et à la contraception

P. Tuppin, J. Rudant, and P. Constantinou, Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'assurance maladie (sniiram) to the système national des données de santé (snds) in france, Rev Epidemiol Sante Publique, vol.65, pp.149-167, 2017.

J. Bezin, M. Duong, and R. Lassalle, The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, pp.954-62, 2017.

P. A. Boyd, M. Haeusler, and I. Barisic, Paper 1: The EUROCAT network--organization and processes, Birth Defects Res A Clin Mol Teratol, vol.91, pp.2-15, 2011.

, EUROCAT Guide 1.4 Section 3.2. Minor anomalies for exclusion, vol.11, 2017.

K. H. Nicolaides, G. Azar, and D. Byrne, Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, BMJ, vol.304, pp.867-876, 1992.

P. Taipale, V. Hiilesmaa, and R. Salonen, Increased nuchal translucency as a marker for fetal chromosomal defects, N Engl J Med, vol.337, pp.1654-1662, 1997.

R. J. Snijders, P. Noble, and N. Sebire, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. fetal medicine foundation first trimester screening group, Lancet, vol.352, pp.343-349, 1998.

. Insee, Âge moyen de la mère à l'accouchement en, vol.11, 2017.

B. Blondel, B. Coulm, and C. Bonnet, Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys, J Gynecol Obstet Hum Reprod, vol.46, pp.701-714, 2017.

E. Garne, M. Loane, and H. Dolk, Prenatal diagnosis of severe structural congenital malformations in Europe, Ultrasound Obstet Gynecol, vol.25, pp.6-11, 2005.

E. Garne, M. Loane, and D. Wellesley, Congenital hydronephrosis: prenatal diagnosis and epidemiology in Europe, J Pediatr Urol, vol.5, pp.47-52, 2009.

P. A. Boyd, C. Devigan, and B. Khoshnood, Survey of prenatal screening policies in europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and down's syndrome, BJOG, vol.115, pp.689-96, 2008.

R. N. Pedersen, E. Calzolari, and S. Husby, Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions, Arch Dis Child, vol.97, pp.227-259, 2012.

E. Garne, Prenatal diagnosis of six major cardiac malformations in Europe--a population based study, Acta Obstet Gynecol Scand, vol.80, pp.224-232, 2001.

P. A. Boyd, M. Loane, and E. Garne, Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy

, Eur J Hum Genet, vol.19, pp.231-235, 2011.

B. Khoshnood, D. Vigan, C. Vodovar, and V. , A population-based evaluation of the impact of antenatal screening for down's syndrome in France, BJOG, vol.111, pp.485-90, 1981.

B. Khoshnood, N. Lelong, and A. Lecourbe, Registre des Malformations Congénitales de Paris (registre qualifié, 2013.